• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of MSC-derived extracellular vesicle for clinical application

Research Project

Project/Area Number 21K06964
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 49030:Experimental pathology-related
Research InstitutionUniversity of Tsukuba

Principal Investigator

Ohneda Osamu  筑波大学, 医学医療系, 教授 (30311872)

Co-Investigator(Kenkyū-buntansha) VUONG CAT・KHANH  筑波大学, 医学医療系, 助教 (20816102)
山下 年晴  筑波大学, 医学医療系, 助教 (50400677)
Project Period (FY) 2021-04-01 – 2024-03-31
Project Status Completed (Fiscal Year 2023)
Budget Amount *help
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2023: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2022: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2021: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Keywords間葉系幹細胞 / 2型糖尿病 / 老化 / 細胞外小胞 / 細胞小胞 / 2型糖尿病 / 若返り
Outline of Research at the Start

間葉系幹細胞(MSC)が幹細胞治療において,汎用性の高い細胞ソースとして使用できるようにするために機能的に優れたMSCを単離できるヒト由来組織を同定し,かつ疾患を有する患者由来MSCの機能異常及び老化によるMSC機能低下を分子レベル で解明し, その機能を補完するための方法を確立する.その一つの手段として,細胞が自ら細胞外に放出する細胞外小胞(EV)が挙げられる.標的とするMSCは,以下の2つである;1)2型糖尿病由来MSC、2)高齢者由来MSC.これら標的とするMSCが機能回復するメカニズムを明らかにすべく,異なる組織由来EVあるいは異なる培養条件下で放出されるEVに対して解析を行う.

Outline of Final Research Achievements

To elucidate functional abnormalities of MSCs derived from patients with diseases (type 2 diabetes) and functional decline of MSCs due to aging at the molecular level, this study was performed. The following studies were conducted using extracellular vesicles (EVs): 1) dEVs derived from dAT-MSCs collected from adipose tissue of patients with type 2 DM were compared with EVs derived from nAT-MSCs of healthy subjects; 2) administration of dEVs to nAT-MSCs did not alter proliferative ability but significantly increased adipogenic differentiation, and 3) the function of hEVs was significantly enhanced in patients with type 2 DM.
Elderly AT-MSCs; eAT-MSCs showed decreased proliferative and differentiation capacity as well as wound healing ability compared to infant AT-MSCs; iAT-MSCs. ROS expression was significantly upregulated in eAT-MSCs compared to i-AT-MSCs, and the increase in ROS was attributed to the decreased expression of Sirtuin-1, a senescence suppression factor.

Academic Significance and Societal Importance of the Research Achievements

Transformed extracellular vesicles with high angiogenic ability as therapeutics of distal ischemic tissues. Front. Cell Dev. Biol.,2022. PMID: 36120585
上記論文を発表することにより、機能性幹細胞から単離された細胞外小胞EVが効果的に標的細胞の性質をトランスフォームすることが可能であることを明らかにした点は、社会的意義が高いものと思われる。

Report

(4 results)
  • 2023 Annual Research Report   Final Research Report ( PDF )
  • 2022 Research-status Report
  • 2021 Research-status Report
  • Research Products

    (3 results)

All 2022 2021

All Journal Article (3 results) (of which Int'l Joint Research: 1 results,  Peer Reviewed: 3 results,  Open Access: 2 results)

  • [Journal Article] Type 2 Diabetes Mellitus Promotes the Differentiation of Adipose Tissue-Derived Mesenchymal Stem Cells into Cancer-Associated Fibroblasts, Induced by Breast Cancer Cells.2022

    • Author(s)
      Chang YH, Ngo NH, Vuong CK, Yamashita T, Osaka M, Hiramatsu Y, Ohneda O.
    • Journal Title

      Stem Cells and Development

      Volume: 31 Issue: 21-22 Pages: 659-671

    • DOI

      10.1089/scd.2022.0086

    • Related Report
      2022 Research-status Report
    • Peer Reviewed
  • [Journal Article] Transformed extracellular vesicles with high angiogenic ability as therapeutics of distal ischemic tissues.2022

    • Author(s)
      Ngo NH, Chang YH, Vuong CK, Yamashita T, Obata-Yasuoka M, Hamada H, Osaka M, Hiramatsu Y, Ohneda O.
    • Journal Title

      Frontier Cell Developmental Biology

      Volume: 10 Pages: 1-15

    • DOI

      10.3389/fcell.2022.869850

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Wharton's Jelly Mesenchymal Stem Cell-Derived Extracellular Vesicles Reduce SARS-CoV2-Induced Inflammatory Cytokines Under High Glucose and Uremic Toxin Conditions2021

    • Author(s)
      Khanh Vuong Cat、Fukushige Mizuho、Chang Yun Hsuan、Hoang Ngo Nhat、Yamashita Toshiharu、Obata-Yasuoka Mana、Hamada Hiromi、Osaka Motoo、Hiramatsu Yuji、Ohneda Osamu
    • Journal Title

      Stem Cells and Development

      Volume: 30 Issue: 15 Pages: 758-772

    • DOI

      10.1089/scd.2021.0065

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research

URL: 

Published: 2021-04-28   Modified: 2025-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi